APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 209 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $112,905,787 | -8.9% | 1,239,361 | -34.1% | 0.34% | -12.5% |
| Q1 2023 | $123,986,595 | +4915.6% | 1,879,724 | +2406.3% | 0.38% | +3390.9% |
| Q3 2021 | $2,472,000 | -77.0% | 75,000 | -70.0% | 0.01% | -78.0% |
| Q1 2021 | $10,728,000 | +701.8% | 250,000 | +968.4% | 0.05% | +614.3% |
| Q4 2020 | $1,338,000 | -90.1% | 23,400 | -94.8% | 0.01% | -89.9% |
| Q3 2020 | $13,484,000 | +98.4% | 446,936 | +114.8% | 0.07% | +56.8% |
| Q2 2020 | $6,797,000 | -20.8% | 208,103 | -35.0% | 0.04% | -37.1% |
| Q1 2020 | $8,581,000 | -15.6% | 320,301 | -20.1% | 0.07% | +32.1% |
| Q2 2019 | $10,164,000 | +56.2% | 401,104 | +20.2% | 0.05% | +76.7% |
| Q1 2019 | $6,506,000 | +344.4% | 333,629 | +200.5% | 0.03% | +328.6% |
| Q4 2018 | $1,464,000 | – | 111,016 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |